RAYMOND JAMES & ASSOCIATES - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$329,000
-50.1%
4,825
-49.2%
0.00%
-100.0%
Q1 2021$659,000
-0.3%
9,496
+10.4%
0.00%0.0%
Q4 2020$661,000
-26.6%
8,605
-28.6%
0.00%0.0%
Q3 2020$901,000
+26.4%
12,053
+6.4%
0.00%0.0%
Q2 2020$713,000
+50.4%
11,327
+0.3%
0.00%0.0%
Q1 2020$474,000
-11.1%
11,295
-3.7%
0.00%0.0%
Q4 2019$533,000
-26.2%
11,735
-25.6%
0.00%0.0%
Q3 2019$722,000
-23.4%
15,783
-1.7%
0.00%0.0%
Q2 2019$942,000
+20.5%
16,062
-7.9%
0.00%0.0%
Q1 2019$782,00017,4330.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 4,190,000$321,918,0005.54%
Prosight Management, LP 145,700$11,194,0005.17%
Integral Health Asset Management, LLC 200,000$15,366,0004.57%
Copernicus Capital Management, LLC 3,740$287,0004.47%
GREAT POINT PARTNERS LLC 345,120$26,516,0004.31%
Asymmetry Capital Management, L.P. 101,245$7,779,0003.55%
First Light Asset Management, LLC 321,967$24,737,0001.83%
DAFNA Capital Management LLC 76,815$5,902,0001.76%
SECTORAL ASSET MANAGEMENT INC 320,059$24,590,0001.73%
Nicholas Investment Partners, LP 276,633$21,254,0001.64%
View complete list of ARENA PHARMACEUTICALS INC shareholders